510(k) K960257

N ANTISERUM TO C1 INHIBITOR by Behring Diagnostics, Inc. — Product Code DBA

K960257 is an FDA 510(k) premarket notification submitted by Behring Diagnostics, Inc. for the device "N ANTISERUM TO C1 INHIBITOR". The FDA issued a decision of Substantially Equivalent on Aug 1, 1996. The device falls under product code DBA (Complement C1 Inhibitor (Inactivator), Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 866.5250. Behring Diagnostics, Inc. has 144 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Aug 1, 1996
Date Received
Jan 18, 1996
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Complement C1 Inhibitor (Inactivator), Antigen, Antiserum, Control
Device Class
Class II
Regulation Number
866.5250
Review Panel
IM
Submission Type
510(k)

Need the full FDA record for Behring Diagnostics, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K960257. Report a data issue: hello@regdatalab.com.